Quadrant Capital Group LLC

SEC CIK: 0001650717
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CCCC holding history

C4 Therapeutics, Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CCCC overview All 13F holders of CCCC Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2021

Holdings of CCCC by Quadrant Capital Group LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−22−100.0%	Sold out	Holders
Q1 2022	22	$1.00K	<0.1%	+22	New	Holders
Q4 2021	0	$0	0.0%	−4−100.0%	Sold out	Holders
Q3 2021	4	$0	0.0%	+4	New	Holders